.

Vital Therapies reported $397K in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Dynavax Technologies DVAX:US $ 174.24M 37.31M
Enanta Pharmaceuticals ENTA:US $ 48.21M 0.74M
Epizyme EPZM:US $ 11.21M 5.31M
Insmed INSM:US $ 29.48M 3.76M
Intercept Pharmaceuticals ICPT:US $ 27.52M 18.63M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Omeros OMER:US $ 58.27M 2.09M
Orasure Technologies OSUR:US $ 62.89M 3.22M
Quidel QDEL:US $ 379.2M 210.76M
Revance Therapeutics RVNC:US $ 5.59M 1.12M
Ultragenyx Pharmaceutical RARE:US $ 37.21M 8.84M
United Therapeutics UTHR:US $ 173.4M 2.9M
Vital Therapies VTL:US $ 0.4M 0.19M
Xoma XOMA:US $ 2.5M 2.48M